EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Fibrocytes in tumor microenvironment: Identification of their fraction and novel therapeutic strategy

Atsushi Mitsuhashi, Yasuhiko Nishioka iD

Cancer Science · 2025

DOI: 10.1111/cas.16385 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Science, 2025. Verfasst von Atsushi Mitsuhashi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine and Rheumatology, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan. Hauptthemen laut MEDLINE: Tumor Microenvironment, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Science and Technology Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fibrocytes were identified as bone marrow‐derived myeloid cells that also have fibroblast‐like phenotypes, such as ECM production and differentiation to myofibroblasts. Although fibrocytes are known to contribute to various types of tissue fibrosis, their functions in the tumor microenvironment are unclear. We focused on fibrocytes as pivotal regulators of tumor progression. Our previous studies have indicated that fibrocytes induce angiogenesis and cancer stem cell‐like phenotypes by secreting various growth factors. In contrast, immune checkpoint inhibitor (ICI)‐treated fibrocytes demonstrated antigen‐presenting capacity and enhanced antitumor T cell proliferation. Taken together, these findings indicate that fibrocytes have multiple effects on tumor progression. However, the detailed phenotypes of fibrocytes have not been fully elucidated because the isolation of distinct fibrocyte clusters has not been achieved without culturing in ECM‐coated conditions or intracellular staining of ECM. The development of single‐cell analyses partially resolves these problems. Single‐cell RNA sequences in CD45 + immune cells from tumor tissue identified ECM‐expressing myeloid‐like cells as distinct fibrocyte clusters. In addition, these findings enabled the isolation of tumor‐infiltrating fibrocytes as CD45 + CD34 + cells. These tumor‐infiltrating fibrocytes demonstrated both antigen‐presenting ability and differentiation into myofibroblast‐like cancer‐associated fibroblasts. Considering these functions of fibrocytes in tumor progression, molecular‐targeting agents for the migration, activity, and differentiation of fibrocytes are promising therapeutic strategies. Furthermore, identification of specific cell surface markers and master regulators of fibrocytes will advance novel fibrocyte‐targeting therapies. In this review, we discuss the multiple roles of tumor‐infiltrating fibrocytes and novel cancer therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentNeoplasmsHumansCell DifferentiationAnimalsMyeloid CellsCancer-Associated FibroblastsImmune Checkpoint InhibitorsSingle-Cell AnalysisFibroblastsNeovascularization, PathologicExtracellular MatrixMyofibroblasts

Stichwörter der Autor:innen

angiogenesiscancer stem cellcancer‐associated fibroblastfibrocyteimmune checkpoint inhibitor

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Respiratory Medicine and Rheumatology, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan.
  • Department of Community Medicine for Rheumatology, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan.

ORCID-Profile: Yasuhiko Nishioka

Förderung

  • Japan Society for the Promotion of Science
  • Japan Science and Technology Agency

Zitieren

APA

Mitsuhashi, A., & Nishioka, Y. (2025). Fibrocytes in tumor microenvironment: Identification of their fraction and novel therapeutic strategy. Cancer Science. https://doi.org/10.1111/cas.16385

Vancouver

Mitsuhashi A, Nishioka Y. Fibrocytes in tumor microenvironment: Identification of their fraction and novel therapeutic strategy. Cancer Science. 2025. doi:10.1111/cas.16385

BibTeX
@article{Mitsuhashi2025,
  author = {Mitsuhashi, Atsushi and Nishioka, Yasuhiko},
  title = {Fibrocytes in tumor microenvironment: Identification of their fraction and novel therapeutic strategy},
  journal = {Cancer Science},
  year = {2025},
  doi = {10.1111/cas.16385}
}
Kostenlos starten →